4/A//SEC Filing
Dorman H. Paul 4/A
Accession 0001181431-13-025191
CIK 0001533040other
Filed
May 2, 8:00 PM ET
Accepted
May 3, 5:31 PM ET
Size
5.3 KB
Accession
0001181431-13-025191
Insider Transaction Report
Form 4/AAmended
Dorman H. Paul
Director
Transactions
- Award
Stock Option (right to buy)
2013-04-18+1,000,000→ 1,000,000 totalExercise: $0.24Exp: 2023-04-18→ Common stock (1,000,000 underlying)
Footnotes (1)
- [F1]The award will vest in equal quarterly installments of 250,000 shares on each of July 18, 2013, October 18, 2013, January 18, 2014, and April 18, 2014.
Documents
Issuer
RXi Pharmaceuticals Corp
CIK 0001533040
Entity typeother
Related Parties
1- filerCIK 0001575028
Filing Metadata
- Form type
- 4/A
- Filed
- May 2, 8:00 PM ET
- Accepted
- May 3, 5:31 PM ET
- Size
- 5.3 KB